4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Valneva SE (VALN) operates in the Biotechnology industry and is headquartered in Saint-Herblain, France with about 620 employees. Its market capitalization is roughly $653 million. In the fiscal year ended 2025-12-31, VALN reported €175M in revenue and (€115M) in net income.
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
Interactive charts & full statements → Open the VALN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €175M | €170M | €154M | €361M | — |
| Gross Profit | €68M | €71M | €53M | €37M | — |
| Operating Income (EBIT) | (€82M) | (€78M) | (€82M) | (€113M) | — |
| Net Income | (€115M) | (€12M) | (€101M) | (€143M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | €35M | €31M | €48M | €29M | €48M | — | — |
| Gross Profit | €2M | €5M | €12M | €6M | €24M | — | — |
| Operating Income (EBIT) | (€26M) | (€24M) | (€28M) | (€37M) | (€11M) | — | — |
| Net Income | (€31M) | (€32M) | (€50M) | (€44M) | (€12M) | — | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | €0M | €0M | €0M | €0M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Dividends Paid | €0M | €0M | €0M | €0M | €0M | — | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €399M | €500M | €460M | €621M | — |
| Total Liabilities | €293M | €319M | €332M | €402M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VALN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms